Subsequent studies validated that LKB1 overexpression could strengthen the inhibition of EMT mediated by oridonin, suggesting a vital role of LKB1 in anti-metastatic effect of oridonin on laryngeal carcinoma. This evidence concerns the gene STK11 and laryngeal carcinoma.